COMP <GO>
CPAY vs PG // FORWARD P/E MULTIPLE
Corpay Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CPAY 7
— PG 7
▲ FORWARD P/E MULTIPLE LEADER: CPAY
LAST: $400.94 (+0.75%) • MKT CAP: $26.13B
forward-pe
20.5x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
forward-pe
21.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPAY VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPAY | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.20% | 25.40% | -2.20 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.4x | 16.2x | -2.80 | CPAY | /valuation <GO> |
| Free Cash Flow Yield | 4.97% | 3.77% | +1.20 | CPAY | /fcf-yield <GO> |
| Operating Margin | 44.00% | 24.30% | +19.70 | CPAY | /operating-margins <GO> |
| Net Profit Margin | 23.60% | 19.00% | +4.60 | CPAY | /net-margins <GO> |
| Revenue Growth (YoY) | 13.90% | 0.30% | +13.60 | CPAY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.19 | 5.59 | -3.40 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.50% | +0.80 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.8 | 62.7 | -12.92 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.87 | +0.24 | CPAY | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 20.5x | 21.7x | -1.20 | CPAY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $26.13B | $372.21B | -$346.08B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPAY REV | PG REV | CPAY GROSS % | PG GROSS % | CPAY FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.53B | $84.28B | 44.0% | 51.2% | $1.30B | $14.04B |
| FY 2024 | $3.97B | $84.04B | 44.0% | 51.4% | $1.77B | $16.52B |
| FY 2023 | $3.76B | $82.01B | 44.0% | 44.0% | $1.93B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPAY // BETA 1.11
PG // BETA 0.87